Prescribed Medications and OTCs: Interactions and Timing Issues
|
|
- Darren Sanders
- 5 years ago
- Views:
Transcription
1 In Brief This article describes some common drug-drug interactions between prescription medications and over-the-counter medications that people with diabetes might encounter. With each interaction listed, there is a description of how to appropriately manage it. Also, proper timing of the medications in relation to food intake is described. The data presented are not all-inclusive but do detail the common medications used in people with diabetes. Prescribed Medications and OTCs: Interactions and Timing Issues 256 Kimberly R. Rhoades, RPh, CDE An estimated 17 million people in the United States have diabetes. This is ~6.2% of the population. 1 The majority of the premature deaths attributed to diabetes are a result of complications from the disease. 2 Approximately 73% of adults with diabetes have high blood pressure or use prescription medications to help control hypertension. Adults with diabetes are also two to four times more likely to die from heart disease or to have a stroke than are those without diabetes. 1 The macrovascular diseases, such as arteriosclerosis, are one of the many reasons for the increased incidence of heart disease and stroke. National guidelines now suggest more stringent blood pressure and cholesterol targets than in the past. Therefore, people with diabetes are more likely to be prescribed multiple medications to control these concurrent disease states. The greater the number of medications a person is taking, the greater the risk for drug-drug interactions. According to one hospital study, 3 33% of all adverse drug reactions (ADRs) were a result of preventable drug interactions. This percentage may be even larger if over-the-counter (OTC) product use were taken into account. Drug interactions between common prescription medications and OTCs that a person with diabetes might encounter will be discussed further in this article. Common classes of prescription medications used in diabetes are antidiabetic agents, antihypertensive agents, and antilipemic agents. Common OTCs include analgesics, cough and cold products, and antacids/laxatives. Drug-drug interactions among these classes of medications, as well as the few drug-disease interactions possible with these agents, will be reviewed. Thousands of drug-drug interactions have been documented. However, only a small percentage of these are clinically important. To help clinicians determine the clinical significance of a drug interaction, rating systems have been established. Most rating systems use a numerical scale. This article will draw upon the rating scales developed by Facts and Comparisons 4 and Hansten and Horn. 5 The two scales stratify drug interactions by their severity and documentation of supporting biomedical literature. Hansten and Horn assess severity and documentation together, whereas Facts and Comparisons assesses each of these individually first and then assigns a rating. Facts and Comparisons ratings will be referred to as significance rating A, and the rating provided by Hansten and Horn will be referred to as significance rating B. When assessing severity, Facts and Comparisons labels the interactions as Major, Moderate, or Minor. Major interactions are those in which the effect is potentially capable of causing permanent damage. Moderate interactions are those that may cause deterio-
2 ration in the clinical status of a patient. Minor interactions are those in which the consequences may be bothersome but should not significantly affect outcomes. Facts and Comparisons categorizes the documentation in the literature as Established, Probable, Suspected, Possible, or Unlikely. Established documentation has been proven to occur in well-controlled studies. Probable documentation is very likely to occur but not proven clinically. Suspected documentation means that it may occur and that there are good data, but that more studies are needed to confirm. Possible documentation means that it may occur, however there is limited data. Unlikely documentation means the interaction is doubtful because there is no good evidence supporting it. Finally, a numerical rating of 1 to 5 is assigned. A level 1 rating is most Prescription Drug Antihypertensive Agents Table 1. Significance Rating Scales Source A 4 Source B 5 Severity of Support from Assigned Rating Avoidance Risk Consequences Literature A & B Major Probable or 1 Avoid Suspected combination Moderate Probable or 2 Avoid combination Suspected if possible Minor Probable 3 Monitor and take or Suspected action if necessary Major/Moderate Possible 4 No action necessary Minor Unlikely or Possible 5 No interaction severe and has a very high probability of occurring. A level 4 or 5 rating is considered mild and of low probability. Table 1 outlines the stratification and the assigned numerical rating. The majority of pharmacies throughout the country screen for drug-drug Table 2. Prescription Drug and OTC Interactions OTC Significance Rating A 4 B 5 interactions among prescription medications dispensed. Unfortunately, this screening process is not available when OTCs are purchased. Labeling regulations for OTCs require the manufacturers to list potential interactions with medications and disease states. Description and Management From Research to Practice / Polypharmacy: Boon or Bane? ACE INHIBITORS Benazepril (Lotensin), captopril (Capoten),* enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril), ramipril (Altace), quinapril (Accupril) Antacids (aluminum hydroxide, magnesium hydroxide) 5 Not rated Antacids may reduce the absorption and effectiveness of captopril. Separate the administration of each by 2 hours. Benazepril, captopril, enalapril, fosinopril, lisinopril, ramipril, quinapril Capsaicin 5 Not rated Capsaicin may exacerbate the ACE inhibitor related cough. Case reports have occurred with topical application as well as inhaled capsaicin. Benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril (Univasc), ramipril, quinapril, trandolapril (Tarka) bismuth subsalicylate, High-dose salicylates inhibit prostacyclin synthesis, which may decrease the hypotensive and vasodilator effects of ACE inhibitors. Monitor blood pressure and either reduce the dosage of aspirin or change to an alternative agent. -BLOCKERS Acebutolol (Sectral), atenolol (Tenormin), betaxolol (Kerlone), bisoprolol (Zebeta), carteolol (Cartrol), metoprolol (Lopressor, Toprol), nadolol (Corgard), penbutolol (Levatol), pindolol (Visken), propranolol (Inderal), timolol (Blocadren), sotalol (Betapace) Aluminum salts (aluminum carbonate, aluminum hydroxide, aluminum phosphate, attapulgite, kaolin, magaldrate) 3 4 Reduced absorption and delayed gastric emptying may alter the effect of -blockers. Separate the administration of each by 2 hours. propranolol, timolol, sotalol Calcium salts (calcium carbonate, calcium citrate, calcium gluconate, calcium lactate, dibasic calcium phosphate) Calcium salts may impair the absorption of -blockers. Monitor for signs of decreased efficacy and adjust dosage if necessary. Continued on p
3 Table 2. Prescription Drug and OTC Interactions, Cont. Prescription Drug OTC Significance Rating A 4 B 5 Description and Management -BLOCKERS cont. propranolol, timolol, sotalol Cimetidine 2 4 Cimetidine may reduce hepatic clearance of -blockers creating an increased effect. Monitor for signs of toxicity and adjust dosage if necessary or change to alternative histamine2-blocker. propranolol, timolol NSAIDs (ibuprofen, indomethacin, naproxen, piroxicam) NSAIDs may decrease the antihypertensive effect of -blockers by inhibiting prostaglandin synthesis. Monitor blood pressure and adjust -blocker dosage if necessary. propranolol, timolol bismuth subsalicylate, 4 4 High-dose salicylates may alter the effect of -blockers by inhibition of prostaglandins. Monitor blood pressure and adjust dosage if necessary or change to alternative agent. CALCIUM-CHANNEL BLOCKERS Diltiazem (Cardizem, Cartia XL, Dilacor, Tiazac), nifedipine (Adalat, Procardia), nisoldipine (Sular), verapamil (Calan, Covera, Isoptin, Verelan) Calcium salts (calcium carbonate, calcium citrate, calcium gluconate, calcium lactate, dibasic calcium phosphate) When large doses of calcium salts are given, a reduction of the hypotensive effects of calcium-channel blockers may be seen. Monitor vital signs and adjust dosages if necessary. Diltiazem, nifedipine, nisoldipine, verapamil Histamine2 antagonists (cimetidine, ranitidine, famotidine) Cimetidine may increase the plasma concentration of calcium-channel blockers, creating an increase in hypotensive effects. Monitor blood pressure and adjust dosage if necessary or change to alternative agent. LOOP DIURETICS Bumetanide (Bumex), ethacrynic acid (Edecrin), furosemide (Lasix), torsemide (Demadex) NSAIDs (diclofenac, ibuprofen, indomethacin, ketoprofen, naproxen, sulindac, oxaprozin, piroxicam) 3 3 NSAIDs may decrease the effectiveness of loop diuretics. Monitor for reduction of efficacy and adjust loop diuretic dosage if necessary or change to alternative NSAID. Bumetanide, ethacryinic acid, furosemide, torsemide bismuth subsalicylate, 5 4 A decreased diuretic response may be possible in patients with cirrhosis and ascites. Monitor these patients for decreased effect and adjust dosage if necessary. THIAZIDE DIURETICS Chlorothiazide (Diuril), chlorthalidone (Hygroton), hydrochlorothiazide (Esidrix, HydroDiuril, Oretic), indapamide (Lozol), metolazone (Zaroxolyn) Calcium salts (calcium carbonate, calcium citrate, calcium gluconate, calcium lactate, dibasic calcium phosphate) Hypercalcemia may result from this combination. Monitor serum calcium and for signs of hypercalcemia. Avoid excessive or prolonged administration of calcium salts. Chlorothiazide, chlorthalidone, hydrochlorothiazide, indapamide, metolazone NSAIDs (diclofenac, ibuprofen, indomethacin, ketoprofen, naproxen, sulindac, oxaprozin, piroxicam) 5 4 NSAIDs may cause a mild reduction in antihypertensive effects of thiazide-type diuretics by induction of sodium/water retention and inhibition of renal prostaglandin. Monitor blood pressure and adjust dosage if necessary. Continued on p
4 Prescription Drug Antidiabetic Agents INSULINS AND SULFONYLUREAS Insulin, chlorpropamide (Diabenese), glipizide (Glucotrol), glyburide (DiaBeta,Micronase), tolbutamide (Orinase) Chlorpropamide, glipizide, glyburide, tolbutamide Acetohexamide (Dymelor), chlorpropamide, glipizide, glyburide, tolazamide (Tolinase), tolbutamide) Metformin (Glucophage) Antihyperlipemic Agents BILE AND SEQUESTRANTS Cholestyramine (Questran, Prevalite), colestipol (Colestid), colesevelam (Welchol) Table 2. Prescription Drug and OTC Interactions, Cont. OTC Magnesium salts (magnesium-aluminum hydroxide, magnesium hydroxide) Histamine2 antagonists (cimetidine, ranitidine, famotidine) Cimetidine NSAIDs (ibuprofen, ketoprofen, naproxen sodium) Significance Rating A 4 B Description and Management Salicylates may enhance insulin secretion and may increase the effectiveness of sulfonylureas. Monitor blood glucose and adjust medications if necessary. Magnesium salts may enhance absorption of sulfonylureas, therefore increasing the hypoglycemic effect. Monitor blood glucose and adjust dosage if necessary. Reduced hepatic metabolism of sulfonylureas may occur, and changes in gastric ph may lead to increases in efficacy of sulfonylureas. Monitor blood glucose levels and adjust dosages if necessary. Cimetidine increases metformin concentrations by reducing renal clearance, thereby increasing the blood glucose lowering effect. Monitor blood glucose and adjust dosage if necessary or change to alternative histamine2 antagonist. Bile acid sequestrants may decrease the effectiveness of NSAIDs. Take the NSAID either 2 hours before or 6 hours after the administration of the bile acid sequestrant. From Research to Practice / Polypharmacy: Boon or Bane? OTHERS Niacin (Niacor, Niaspan) Salicylates (aspirin) 5 4 Aspirin reduces the cutaneous flushing and increases the plasma concentration of niacin. *Italics indicate medications specifically reported in the literature Certain classes of medications tend to have a higher incidence of drug interactions. According to one hospital study in Germany, 6 thiazide diuretics and angiotensin-converting enzyme (ACE) inhibitors had the highest percentage of potential interactions compared to other classes of antihypertensive medications. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) recommends these two classes of medications as preferred agents in people with diabetes. While these medications clearly benefit this patient population, their use also puts this group of patients at higher risk for drug-drug interactions. Because this patient population is at high risk for cardiovascular events, blood pressure control must be aggressively approached. JNC VI recommends lowering blood pressure in this population to <130/85 mmhg, whereas the American Diabetes Association recommends lowering it to <130/80 mmhg. 7,8 People with diabetes and hypertension are more likely to be taking more than one class of antihypertensive medication regardless of the target recommended. Five classes of antihypertensive medications have been included in this article. ACE inhibitors, -adrenergic blockers, calcium-channel blockers, loop diuretics, and thiazide diuretics, and their interactions with OTC analgesics and antacids are described. By far, the antihypertensives have more interactions with OTCs than do the two other classes reviewed. Table 2 outlines the interactions, significance ratings assigned, and possible courses of management. OTC cough and cold medications have more drug-disease interactions than drug-drug interactions. Table 3 outlines the OTCs and their possible negative effects in people with diabetes. Because people with diabetes are more likely to have high blood glucose, hypertension, and poor circulation, OTCs to be concerned about are those that may increase blood glucose, increase blood pressure, or constrict blood vessels. Decongestants may affect blood pressure and circulation. Cough syrups may contain several different ingredients, including decongestants, and are available with and without added sugar. Therefore, they 259
5 Medication ANTIHISTAMINES Brompheniramine, chlorpheniramine, clemastine, dexbrompheniramine, diphenhydramine, triprolidine ANTITUSSIVES Dextromethorphan, diphenhydramine ANTIHYPERLIPEMICS Niacin Effect on Disease State Typically this class of medication causes no detrimental effect on the disease state. Typically this class of medication has no effect on blood glucose. However, there are two pediatric case reports in which high doses of dextromethorphan caused a reversible type 1 diabetes. 10 Niacin may increase blood glucose levels. Monitor blood glucose and make appropriate adjustments if necessary or change to alternative agent. DECONGESTANTS Ephedrine, naphazoline,* oxymetazoline, Decongestants may increase blood phenylephrine, pseudoephedrine, pressure secondary to vasoconstrictive xylometazoline properties. Monitor blood pressure and adjust dosage if necessary. EXPECTORANTS Guaifenesin Table 3. OTC Drug-Disease Interactions Typically this medication causes no detrimental effect on the disease state. *The products underlined represent the topical nasal decongestants. Systemic effects are less likely to occur with topical use. of a medication, it is helpful to know when the medication should be administered with regard to meals. As outlined in Table 4, most antidiabetic medications achieve maximum efficacy when taken before meals. Yet, most antihypertensive medications can be taken without regard to food. Generally speaking, if a medication causes stomach upset when taken on an empty stomach, taking it with a little bit of food may hinder the absorption slightly but certainly not as significantly as not taking the medication at all. In conclusion, medications are prescribed to improve quality and quantity of life. Medications should be effective for the diagnosis, be easy to administer, and cause a minimum of side effects. To achieve maximum efficacy of a medication, drug-drug interactions, drug-disease interactions, and the timing of administration with respect to food should be examined thoroughly before coadministration of multiple medications. This article provides a reference to may alter glucose, circulation, and/or blood pressure. It would be prudent to counsel patients to read labels on these products to identify potential interactions. A study performed in a U.S. Army Medical Center 9 showed no significant adverse effects on blood glucose levels when people with diabetes took sugar-containing cough formulas in short courses. Most health care providers would agree that if a patient s glucose and blood pressure are stable and reasonably well controlled, the short-term use of OTC cough and cold products should be of little risk. In summary, the effects of OTCs on patients with diabetes are variable and unpredictable. The best advice is to monitor glucose and blood pressure routinely when starting or stopping any OTC agent and to adjust medications if necessary. In addition to assessing the potential for drug-drug and drug-disease interactions, diabetes health care professionals must also monitor for drugfood interactions. In other words, what is the most appropriate time to take medications in regard to food intake? Food may hinder absorption or increase absorption of a medication. To obtain the maximum efficacy Medication Antidiabetic Agents INSULIN Aspart (Novolog) Lispro (Humalog) Regular (Humulin, Novolin) Glargine (Lantus) Isophane and zinc suspensions (Humulin, Novolin) SULFONYLUREAS Chlorpropamide Glimepiride (Amaryl) Glipizide Glyburide Tolazamide Tolbutamide -GLUCOSIDASE INHIBITORS Acarbose (Precose) Miglitol (Glyset) BIGUANIDES Metformin Table 4. Timing of Administration 11 Timing of Administration Within 5 10 minutes before a meal Within 15 minutes before a meal Take minutes before a meal Take at the same time of day, usually in the evening May be given with a meal or upon awakening or at bedtime Take 30 minutes before a meal to improve effectiveness Take with the first bite of each main meal Take with the first bite of each main meal Take with meals to lessen gastrointestinal upset Continued on p
6 Medication MEGLITINIDES Repaglinide (Prandin) Nateglinide (Starlix) THIAZOLIDINEDIONES Rosiglitazone (Avandia) Pioglitazone (Actos) Antihypertensive Agents ACE INHIBITORS Benazepril, enalapril, fosinopril, lisinopril, ramipril Captopril, moexipril Timing of Administration Usually taken 15 minutes before meals but may be taken immediately preceding meal to 30 minutes before the meal Take 1 30 minutes before meals Take 1 hour before meals ANGIOTENSIN II RECEPTOR ANTAGONISTS Candesartan (Atacand), losartan (Cozaar), irbesartan (Avapro) Telmisartan (Micardis), valsartan Take 1 hour before meals (Diovan) -BLOCKERS bisoprolol, carteolol, nadolol, sotalol Metoprolol, propranolol ; however, food may enhance the bioavailability CALCIUM-CHANNEL BLOCKERS Amlodipine (Norvasc), bepridil (Vascor), diltiazem, felodipine (Plendil), isradipine (Dynacirc), nicardipine (Cardene), nifedipine, verapamil THIAZIDE DIURETICS Benzthiazide, chlorothiazide, chlorthalidone, hydrochlorothiazide, indapamide, metolazone Antihyperlipemic Agents Table 4. Timing of Administration 11, Cont. BILE ACID SEQUESTRANTS Cholestryramine, colestipol, colesevelam FIBRIC ACID DERIVATIVES Clofibrate (Atromid), fenofibrate (Tricor), gemfibrozil (Lopid) Usually taken before meals HMG CoA REDUCTASE INHIBITORS Atorvastatin (Lipitor), fluvastatin, (Lescol), pravastatin (Pravachol), usually taken in the evening; however, simvastatin (Zocor) high doses may be split between morning and evening Lovastatin (Mevacor) Take with meals, usually in the evening; however, high doses may be split between morning and evening aid in this evaluation. The data presented are not all-inclusive but do detail the common issues surrounding medication use in people with diabetes. References 1 National Diabetes Statistics, health/diabetes/pubs/dmstats/dmstats.htm 2 Miyashiro LA: Diabetes mellitus. In Pharmacotherapy Self Assessment Program. 4th ed. Book 3. Kansas City, Mo. American College of Clinical Pharmacy, p Ferrill M: Clinically relevant drug interactions. In Drug Facts and Comparisons News. St. Louis, Mo., Facts and Comparisons, Nov. 1999, p Tatro DS: Drug Interaction Facts. St. Louis, Mo., Facts and Comparisons, April Hansten PD, Horn JR: Drug Interaction Analysis and Management. St. Louis, Mo., Facts and Comparisons, July Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH: Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38: , The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). NIH Publication No , Nov 1997, p American Diabetes Association: Treatment of hypertension in adults with diabetes (Position Statement). Diabetes Care 25 (Suppl. 1):S71 S73, LeMar HJ Jr, Georgitis WJ: Effect of cold remedies on metabolic control of NIDDM. Diabetes Care 16: , Konrad D, Sobetzko D, Schmitt B, Schoenle EJ: Insulin-dependent diabetes mellitus induced by the antitussive agent dextromethorphan (Letter). Diabetologia 43: , Drug Facts and Comparisons. St. Louis, Mo., Facts and Comparisons, April 2002 Kimberly R. Rhoades, RPh, CDE, is a clinical pharmacist with Kaiser Permanente Colorado in Lakewood, Colo. From Research to Practice / Polypharmacy: Boon or Bane? OTHERS Niacin Take with food 261
Cardiac Medications At A Glance
Cardiac Medications At A Glance 1) Anticoagulants (Also known as Blood Thinners.) Dalteparin (Fragmin), Danaparoid (Orgaran) Enoxaparin (Lovenox) Heparin (various) Tinzaparin (Innohep) Warfarin (Coumadin)
More informationValue-Based Drug List for ABCs of Diabetes
Effective January 1, 2019 Value-Based Drug List for ABCs of Diabetes PCPS provides a Value-Based Benefit Design (VBD) to qualified participants in the ABCs of Diabetes. This means you will have lower out-of-pocket
More informationPassAssured's Pharmacy Technician Training Systems. Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC
Medication Review Cardiovascular Drugs Pharmacy Technician Training Systems Passassured, LLC p1 Medication Review, Cardiovascular Drugs Click Here for Glossary Index! Click Here to Print Topic Help File
More informationPreventing and Managing High Blood Pressure
MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Preventing and Managing High Blood Pressure About This Kit Fortunately, high blood pressure is easily detected and
More informationWORKING TOGETHER TO MANAGE DIABETES
WORKING TOGETHER TO MANAGE DIABETES DIABETES MEDICATIONS SUPPLEMENT SECTION A DIABETES MEDICATIONS Agent Class Primary Action Typical Dosage Side Effects Tolbutamide (Ornase TM ) Tolazamide (Tolinase TM
More informationAdditional Standard Generics HSA Preventive Drug List Effective January 1, 2019
Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019 Employers can elect to include an additional generic HSA Preventive Drug coverage feature with your prescription benefit
More informationPDF created with pdffactory trial version
We are using more prescription drugs than ever before to manage health conditions and prevent problems. And those drugs are more expensive than ever before. In 2003, prescription drug costs in the United
More informationDiabetes and a Healthy Heart. Meeting 6. Welcome! Glucose. Balance Makes a Difference! Medicine Helps with. Glucose. Balance!
6-1 Welcome! Welcome to the lesson! It s good to see you again! Before we visit with Uncle Tommy and Kaipo, let s take a few minutes to review the last five meetings. Glucose Balance Makes a Difference!
More information12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 9/15, 2/13, 2/08, 5/07 LOB
More informationMEDICATION FACT SHEET
ACE Inhibitors Names of ACE Inhibitors: quinapril (Accupril ), enalapril (Vasotec ), ramipril (Altace ), captopril (Capoten ), fosinopril (Monopril ), benazepril (Lotensin ), lisinopril (Zestril, Prinivil
More informationCARDIAC IMAGING QUESTIONNAIRE
Date of test: / / Month day year Last name First name Middle initial Street address City State Zip code Home phone ( ) - Work phone ( ) - Cell Phone ( ) - Email: Age: Demographics: What is your ethnicity?
More informationInformation in these slides is used with permission from St. Mary s Cardiac Rehab
Information in these slides is used with permission from St. Mary s Cardiac Rehab Prescription Pointers Heart Medications Questions!! 2-4% of patients who visit ER s have experienced a medication misadventure
More informationAnnual Review of Antihypertensives - Fiscal Year 2009
Annual Review of Antihypertensives - Fiscal Year 2009 Oklahoma HealthCare Authority April 2010 Current Prior Authorization Criteria There are 7 categories of antihypertensive medications currently included
More information12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 9/11/2018 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 5/17, 9/15, 2/13, 2/08, LOB
More informationLiving with Congestive Heart Failure: A Guide to a Healthy Heart
Living with Congestive Heart Failure: A Guide to a Healthy Heart Things to Know, Before You Go Dear Patient/Caregiver These are the things you NEED TO KNOW, BEFORE YOU GO. It is very important that you
More informationAdapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017
Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:
More informationMedications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy
Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Competency for CDE Exam 3.1.A Oral Medications for Type 2 Diabetes
More information2017 Preventive Drug List for Consumer Driven Health Plans Core List
2017 Preventive Drug List for Consumer Driven Health Plans Core List Alphabetical Listing Core List A Accupril Accuretic Acebutolol Aceon Actonel Adalat CC Afeditab Aggrenox Aldactazide Aldactone Alendronate
More information4/3/2014 OBJECTIVES BLOOD PRESSURE BASICS. Discuss the new blood pressure guidelines (JNC 8) and recognize the changes from JNC 7
1 OBJECTIVES Discuss the new blood pressure guidelines (JNC 8) and recognize the changes from JNC 7 Review mechanisms for the main drug classes used to treat hypertension Describe the dosing strategies
More informationHypertension Clinical Pearls: We re treating more than a number
Hypertension Clinical Pearls: We re treating more than a number Emily Ashjian, PharmD, BCPS, BCACP February 2017 Learning Objectives Review blood pressure goals and differences between treatment guidelines
More informationBlue Cross KeyRx TK Preventive RX Pack Drug List Large Group Effective January 1, 2019
Blue Cross KeyRx TK Preventive RX Pack Drug List Large Group Effective January 1, 2019 Your employer may have elected to include the KeyRx Turn-Key Preventive Pack Drug List in your benefit plan. Below
More informationHypertension is also an important risk factor in the development of chronic kidney disease and heart failure.
Hypertension Hypertension Hypertension is defined as either a sustained systolic blood pressure of greater than 140 mm Hg or a sustained diastolic blood pressure of greater than 90 mm Hg. Hypertension
More informationASEBP and ARTA TARP Drugs and Reference Price by Categories
ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole
More informationAdditional Standard HSA Preventive Drug List Effective January 1, 2019
Additional Standard HSA Preventive Drug List Effective January 1, 2019 Employers can elect to include an additional HSA Preventive Drug coverage feature with your prescription benefit plan. Below is the
More information8/19/2016. No Conflicts. I struggled with everything cardiac in nursing school.
Cindy Weston, DNP, RN, CCRN, CNS CC, FNP BC Assistant Professor, Texas A&M Health Science Center College of Nursing Describe and define epidemiology and pathophysiology of hypertension Differentiate JNC8
More informationHeart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN
Heart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN Objectives Identify Normal Systolic and Diastolic Blood pressures Recognize common Antihypertensive
More information2012 Preventive Drug List for Consumer Driven Health Plans Core List
2012 Preventive Drug List for Consumer Driven Health Plans Core List Alphabetical Listing Core List A C E J N Accupril Accuretic acebutolol Aceon Actonel Adalat CC Advicor Afeditab Aggrenox Aldactazide
More information2018 Preventive Drug List for Consumer Driven Health Plans Core List
2018 Preventive Drug List for Consumer Driven Health Plans Core List Alphabetical Listing Core List A Accupril Accuretic Acebutolol Aceon Actonel Adalat CC Afeditab Aggrenox Aldactazide Aldactone Alendronate
More informationPharmaceutical Treatment of Hypertension and Dyslipidemia in People With Diabetes: An Educator s Perspective Part I: Hypertension
Pharmaceutical Treatment of Hypertension and Dyslipidemia in People With Diabetes: An Educator s Perspective Part I: Hypertension Deborah Hinnen, ARNP, BC-ADM, CDE, FAAN; Belinda P. Childs, ARNP, MN, BC-ADM,
More informationMedications for Type 2 Diabetes CDE Exam Preparation
Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Agenda Medication
More informationLESSON ASSIGNMENT. After completing this lesson you will be able to:
LESSON ASSIGNMENT SUBCOURSE MD0806 LESSON 7 Therapeutics III. Antihypertensive Agents. LESSON ASSIGNMENT Paragraphs 7-1--7-12. LESSON OBJECTIVES After completing this lesson you will be able to: 7-1. From
More informationNOTES: Anemia Medical condition in which the number of red blood cells (the blood count) is reduced.
Advance care planning A process in which you decide what you would like to happen to you, or not happen to you, if you become unable to make decisions about your healthcare treatment or if you are unable
More informationDRUG CLASSIFICATION. Prevention of Cardiovascular Disease
Generic Preventive Care/ Safe Harbor Drug Program List Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition.
More informationMedicines for Heart Disease
Medicines for Heart Disease There are many medicines to treat heart disease. Ask your doctor, nurse, or pharmacist if you have questions about your medicines. Take medicines as directed. Do NOT stop taking
More information2013 Preventive Drug List for Consumer Driven Health Plans Core List
2013 Preventive Drug List for Consumer Driven Health Plans Core List Alphabetical Listing Core List A C E I M Accupril Accuretic acebutolol Aceon Actonel Adalat CC Advicor Afeditab Aggrenox Aldactazide
More informationMedications and Falls Part 1
Medications and Falls Part 1 Introduction with General Principles and Risk Evaluation for Cardiovascular Medications Dennis J Chapron Medication Safety Pharmacist Saint Francis Hospital and Medical Center
More informationSome Facts. Medications and Falls Part 1. Centers for Disease Control (CDC) Falls Statistics for Older Adults ( 65yrs) 11/27/2018
Medications and Falls Part 1 Introduction with General Principles and Risk Evaluation for Cardiovascular Medications Dennis J Chapron reports no real or potential conflicts of interest relevant to this
More informationRisk factor modification Blood pressure/cholesterol etc. James McCormack, B.Sc. (Pharm), Pharm.D. Professor Faculty of Pharmaceutical Sciences
Risk factor modification Blood pressure/cholesterol etc James McCormack, B.Sc. (Pharm), Pharm.D. Professor Faculty of Pharmaceutical Sciences What Will You Do? You are approximately 45 y/o You have been
More informationACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR
S/N ME OF MEDICATIONS BRANDED/GENERIC DRUG CLASS * UNIT PRICE RANGE (SGD$) 1 ACEBUTOLOL HCL 100MG CAPSULE SECTRAL BETA BLOCKERS 0.50 2 ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS 0.33 3 ALISKIREN
More informationCardiovascular Risk Reduction in Diabetic Mellitus. Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist
Cardiovascular Risk Reduction in Diabetic Mellitus Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist Cardiovascular Risk Reduction in Diabetic Mellitus Disclosures
More informationGeneric Preventive Care/ Safe Harbor Drug Program List
Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition. The Generic Preventive Care/Safe Harbor Drug Program
More informationAmbetter 90-Day-Supply Maintenance Drug List
Ambetter 90-Day-Supply Maintenance Drug List What is the Ambetter 90-Day-Supply Maintenance Drug List? Ambetter 90-Day-Supply Maintenance Drug List is a list of maintenance medications that are available
More informationGregory A. Jicha, M.D. Ph.D. Assistant Professor of Neurology. Sanders Brown Center on Aging
Gregory A. Jicha, M.D. Ph.D. Assistant Professor of Neurology UK Alzheimer s Disease Center Sanders Brown Center on Aging There are now more than 5 million people in the United States living with Alzheimer
More information2019 Preventive Drug List for Consumer Driven Health Plans Core List
Core Drug List 2019 Preventive Drug List for Consumer Driven Health Plans Core List ffective Jan. 1, 2019 This document is a list of Preventive Medications that may be covered under your benefit plan.
More informationSTATE OF NEW YORK DEPARTMENT OF HEALTH
STATE OF NEW YORK DEPARTMENT OF HEALTH Corning Tower The Governor Nelson A. Rockefeller Empire State Plaza Albany, New York 12237 Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner Dennis P. Whalen
More information/ United HealthCare Services, Inc. Page 1 of 7
Accupril Accuretic Acebutolol Aceon Activella Actonel Adalat CC Advicor Afeditab CR Aggrenox Aldactone Aldomet Aldoril Alendronate Alora Altace Altoprev Amiloride/HCTZ Amlodipine Amlodipine/Benazepril
More informationSTATE OF NEW YORK DEPARTMENT OF HEALTH
STATE OF NEW YORK DEPARTMENT OF HEALTH Corning Tower The Governor Nelson A. Rockefeller Empire State Plaza Albany, New York 12237 Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner Dennis P. Whalen
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationClinical Teach-Back Cards
Clinical Teach-Back Cards The Medicare Quality Improvement Organization for Texas TMF Health Quality Institute focuses on improving lives by improving the quality of health care through contracts with
More informationCHAPTER 2. Knowing YOUR MEDICATIONS. Image: istock.com/bakibg. Knowing Your Medications 23
CHAPTER 2 Knowing YOUR MEDICATIONS Knowing Your Medications 23 Image: istock.com/bakibg MEDICATION Prescription medications help your heart get better and protect you from more harm. People who take their
More informationQTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8
2019 LiveWELL Health Plan PREVENTIVE DRUG LIST - GENERIC Names ( Copay) - ALPHABETICAL by DRUG CATEGORY You should always check with your prescriber and/or pharmacist to determine if these alternatives
More information2019 Preventive medications and your plan
2019 Preventive medications and your plan Managing your health with preventive medications Your pharmacy benefit plan includes special coverage for generic preventive medications. These medications help
More informationThe Future of Hypertension and the Optometrist
The Future of Hypertension and the Optometrist Lee Dodge, O.D. Hypertension in the United States Author s Bio Dr. Lee Dodge completed his optometric training in 2005 at the Southern California College
More informationGENERIC DISCOUNT FORMULARY March 2015
Antibiotic Amoxicillin Amoxil 250mg Amoxicillin Amoxil 500mg Amoxicillin Amoxil 125mg/5ml Amoxicillin Amoxil 250mg/5ml Amoxicillin Bid Amoxil 400mg/5ml Amoxicillin Bid Amoxil 200mg/5ml Ampicillin Polycillin
More informationα 1 receptor smooth muscle activation
Drugs in Hypertension Dr. Yuri Clement Pharmacology Unit, FMS Objectives Revision of physiological control of BP. What is hypertension? Associated risks of uncontrolled hypertension ANTIHYPERTENSIVE DRUGS:
More informationCenter and WomenHeart, the National Coalition for Women with Heart Disease.
heart-to-heart The information suggested in this publication is not intended as a substitute for medical advice, nor does it suggest diagnoses for individual cases. Consult your health care professional
More informationPharmacology CME Version. Aaron J. Katz, AEMT-P, CIC
Pharmacology CME Version Aaron J. Katz, AEMT-P, CIC www.es26medic.net Pharmacology The study of drugs Sources, characteristics and effects Always refer to drugs as medications Why bother to study medications?
More information2019 Preventive Drug List
2019 Preventive Drug List Managing your health with preventive medications Your pharmacy benefit plan includes special coverage for generic preventive medications. These medications help protect against
More informationFactors Involved in Poor Control of Risk Factors
Factors Involved in Poor Control of Risk Factors Patient compliance Clinical inertia Health Care System structure 14781 M Limitations of Formal Studies Selection of patients Recruitment and follow-up alter
More informationInstructions and Checklist for Your Heart Procedure
PATIENT EDUCATION Instructions and Checklist for Your Heart Procedure allinahealth.org 2016 ALLINA HEALTH SYSTEM. TM A TRADEMARK OF ALLINA HEALTH SYSTEM. OTHER TRADEMARKS USED ARE OWNED BY THEIR RESPECTIVE
More informationClinical Teach-Back Cards
Clinical Teach-Back Cards The Quality Innovation Network - Quality Improvement Organization (QIN-QIO) for Delaware, Louisiana, New Jersey, Pennsylvania and West Virginia The people at Quality Insights
More informationDiabetes Medications: Oral Anti-Hyperglycemic Medications
Diabetes Medications: Oral Anti-Hyperglycemic Medications Medication Types 1. Biguanides 2. Sulfonylureas 3. Thiazolidinediones (TZDs) 4. Alpha-Glucosidase Inhibitors 5. D-Phenylalanine Meglitinides 6.
More informationSelect Preventive Prescription Drugs Jan. 1, 2018
Select Preventive Prescription Drugs Jan. 1, 2018 In addition to a healthy lifestyle, preventive medications can help you avoid some illnesses and conditions. Zimmer Biomet's medical options Value HSA,
More informationMedications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.
Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you
More informationValue-Based Benefits MEDICATION LIST. by Therapy Class
Value-Based Benefits MEDICATION LIST by Therapy Class The prescription drug coverage under your Healthy Rewards value-based benefits program is designed to increase adherence to medications used to treat
More informationHave You Ever Wondered
Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,
More informationBeta-blockers. Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol.
Drugs of CVS Beta-blockers Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol. Atenolol.cardioselective Propranolol, nonselective Bisoprolol, cardioselective Metoprolol Carvedilol, alpha
More informationIntroducing exciting new Rx benefits 2019
Introducing exciting new x benefits 2019 In 2019, the Middlesex prescription plan is aligning with best-in-class evidence-based practices. Two new tiers will be added that evaluate drugs on the basis of
More informationNovo Nordisk Lilly sanofi aventis
Novo Nordisk Lilly sanofi aventis Announcements TURN OFF CELL PHONES Cell phone police are watching If you need to make a call, leave the room Restrooms Breakroom Low blood sugar Copy of presentation,
More informationCompiled by Nicki Hilliard, Pharm.D., BCNP, FAPhA. Significant Interactions
Presented at the Southwest Chapter Society of Nuclear Medicine Meeting Little Rock, Arkansas March 29, 2008 Inside this handout: Compiled by Nicki Hilliard, Pharm.D., BCNP, FAPhA Drug Radiopharmaceutical
More informationClinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19
Clinical Policy: (Ranexa) Reference Number: CP.PMN.34 Effective Date: 08.01.09 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationQuick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE
Quick Guide to MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE Adapted from The Art and Science of Diabetes Self-Management Education Desk Reference 2017, American Association of Diabetes Educators,
More informationHYPERTENSION High Blood Pressure OMC Wellness Center
Well Aware Health Improvement Program HYPERTENSION High Blood Pressure OMC Wellness Center Click here to continue Authors of information: Cindy Floyd MSN, FNP-BC Director of Wellness and Well Aware Health
More informationDROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC
DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC Pharmacotherapy of HTN Rationale for reducing arterial pressure Reduce cardiac output Reduce heart rate Reduce stroke
More informationAntihypertensive Agents
Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,
More informationChapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
More information9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management
Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH Introduction Background Management 2 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia to care coordinators/
More informationHypertension, Hyperlipidemia and Obesity. Mi-CCSI
Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these
More information第十五章. Diabetes Mellitus
Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances
More informationRPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics
Nov/Dec 2015 Issue 11 RPCC Pharmacy Forum Special Interest Articles: Diabetes Medication Chart Insulin Chart Afreeza Did you know? Exanatide, marketed as Byetta, is the synthetic form of exendin-4, which
More informationPreventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Titration Algorithm
Preventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Algorithm Updated 9/13/2017 PHASE Populations DM: type 2 ASCVD: hx heart attack/cad, CVA, TIA, AAA, Sx PAD Lifestyle Modifications
More informationNew Measure Recommended for Endorsement by PQA
New Measure Recommended for Endorsement by PQA Measure: Statin Use in Persons with Diabetes Description: The percentage of patients ages 40 75 years who were dispensed a medication for diabetes that receive
More informationWell Aware Health Improvement Program HYPERTENSION High Blood Pressure OMC Wellness Center
Well Aware Health Improvement Program HYPERTENSION High Blood Pressure OMC Wellness Center Click here to continue Instruction 1. Scroll through the presentation at your own pace. Please use headphones.
More informationModule 7: Pharmacological Management of Cardiovascular Diseases
Module 7: Pharmacological Management of Cardiovascular Diseases Module Aim This module is an introduction to the pharmacological management of cardiovascular diseases and related risk factors. In this
More informationLiving Better with Heart Failure Caring for your heart
Living Better with Heart Failure Caring for your heart Your Care Team The patient is ultimately responsible for their health and serve as a key member of the treatment plan. Together, you and your care
More informationSouth Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina
South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina 29202-8206 Pharmacy and Therapeutics (P&T) Committee Meeting MINUTES 1. Call To Order A meeting of the
More informationGeneric Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre
Generic Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document
More informationRxBlue 2010 ST Criteria
RxBlue 2010 ST Criteria ANTIDEPRESSANTS - SARAFEM... 10 FLUOXETINE HCL... 10 SARAFEM... 10 SELFEMRA... 10 ANTIDEPRESSANTS- SSRI, SNRI... 11 CELEXA... 11 CITALOPRAM... 11 CYMBALTA... 11 EFFEXOR XR... 11
More informationGuide to the Modernized Reference Drug Program
Guide to the Modernized Reference Drug Program For prescribers and pharmacists Medical Beneficiary and Pharmaceutical Services Division June 1, 2016 Contents 1 Introduction 1 2 About this Guide 2 3 About
More informationDiseases & Conditions
http://my.clevelandclinic.org Diseases & Conditions About Cholesterol-Lowering Drugs Some people have a genetic predisposition to high blood cholesterol levels. These people may need drug therapy in addition
More informationPhysician/Clinic Collaborative Practice Agreement
Physician/Clinic Collaborative Practice Agreement Effective October 1, 2010, Connecticut Senate Bill 428 (PA 10-117) extends to all settings and medical conditions the opportunity for licensed pharmacists
More informationTREAT HEART DISEASE. Taking your heart medicines
TREAT HEART DISEASE Taking your heart medicines Cardiovascular Prevention & Rehabilitation Program Dr. Paul Oh, Medical Director Nicole Sandison, Advanced Practice Leader Valerie Skeffington, Program
More informationCodes for a Medicare claims-based model to predict LVEF class- User Guide
Description and citation: This guide accompanies our manuscript [Desai RJ, Lin KJ, Patorno E, et al. Development and Preliminary Validation of a Medicare Claims Based Model to Predict Left Ventricular
More informationOral and Injectable Medication Options for Diabetes Treatment
Oral and Injectable Medication Options for Diabetes Treatment Presented by: Dr. Daphne E. Smith, Pharm.D., CDE Clinical Assistant Professor/Clinical Pharmacist-University of Illinois at Chicago College
More informationDOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE DOD BENEFICIARY ADVISORY PANEL
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE DOD BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32 C.F.R. 199.21,
More informationAlaska Medicaid 90 Day** Generic Prescription Medication List
1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationIntel Connected Care with Providence 2015 Preventive Drug List
Intel Connected Care with Providence 2015 Preventive Drug List Formulary drugs listed below are covered at 100%, not subject to the deductible for the High Deductible Health Plan (HDHP) and Primary Care
More informationUniform Formulary Beneficiary Advisory Panel Handout September 2005
Uniform Formulary Beneficiary Advisory Panel Handout September 2005 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical-effectiveness
More informationThe ADDITION Study: A study about screening for diabetes. Screening Case Report Form
ADDITION Study, Leicester Participant Identification Label: Date: / / The ADDITION Study: A study about screening for diabetes Screening Case Report Form You will need to have the following things done
More information